PerspectiveLIMITING RISK

Disciplined approach to drug discovery and early development

See allHide authors and affiliations

Science Translational Medicine  27 Jul 2016:
Vol. 8, Issue 349, pp. 349ps15
DOI: 10.1126/scitranslmed.aaf2608

Article Information

vol. 8 no. 349 349ps15

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication February 17, 2016
  • Accepted for publication July 7, 2016
  • .

Author Information

  1. Robert M. Plenge
  1. Merck Research Laboratories, Boston, MA 02115, USA. Email: robert.plenge{at}merck.com

Altmetric

Article usage

Article usage: July 2016 to April 2021

AbstractFullPdf
Jul 2016356211941676
Aug 2016229341364091
Sep 2016378474478
Oct 2016259196265
Nov 2016178127172
Dec 2016179134168
Jan 20171468093
Feb 201712486105
Mar 2017214104164
Apr 2017233150147
May 2017186137132
Jun 201710568112
Jul 201710579129
Aug 20179884116
Sep 2017915865
Oct 20171137776
Nov 20171126656
Dec 2017956277
Jan 2018948581
Feb 20181055041
Mar 20181529770
Apr 20181688295
May 20181077676
Jun 20181147456
Jul 2018827451
Aug 201816171102
Sep 20181821697
Oct 20182021694
Nov 20181623576
Dec 2018825978
Jan 20191321186
Feb 20192621788
Mar 20192310964
Apr 20192710259
May 20193010662
Jun 2019207245
Jul 2019257363
Aug 2019197940
Sep 2019258750
Oct 20195112876
Nov 20193510174
Dec 2019299648
Jan 20203413580
Feb 20203812075
Mar 2020159172
Apr 20202612592
May 20203211758
Jun 20202617950
Jul 2020349541
Aug 20202012336
Sep 20201618058
Oct 20202612058
Nov 20202010922
Dec 20201912938
Jan 20211614150
Feb 20211214656
Mar 20212515941
Apr 202156510

Stay Connected to Science Translational Medicine

Navigate This Article